U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. SYMVESS
  1. Vaccines, Blood & Biologics

STN: 125812
Proper Name: acellular tissue engineered vessel-tyod
Tradename: SYMVESS
Manufacturer: Humacyte Global, Inc.
Indication:

  • Indicated for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible.

Product Information

Supporting Documents

Back to Top